JP Morgan Maintains Overweight on Phibro Animal Health, Raises Price Target to $50
Benzinga Newsdesk 12 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Ekaterina Knyazkova maintains Phibro Animal Health (NASDAQ:PAHC) with a Overweight and raises the price target from $45 to $50.
JP Morgan analyst Ekaterina Knyazkova maintains Phibro Animal Health (NASDAQ:PAHC) with a Overweight and raises the price target from $45 to $50.